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In seven families, six different mutant alleles of TRIOBP on chromosome 22q13 cosegregatewith autosomal recessive
nonsyndromic deafness. These alleles include four nonsense (Q297X, R788X, R1068X, and R1117X) and two
frameshift (D1069fsX1082 and R1078fsX1083) mutations, all located in exon 6 of TRIOBP. There are several
alternative splice isoforms of this gene, the longest of which, TRIOBP-6, comprises 23 exons. The linkage interval
for the deafness segregating in these families includes DFNB28. Genetic heterogeneity at this locus is suggested by
three additional families that show signiﬁcant evidence of linkage of deafness to markers on chromosome 22q13
but that apparently have no mutations in the TRIOBP gene.
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Hereditary hearing loss unaccompanied by other asso-
ciated clinical features is referred to as “nonsyndromic”
and is a genetically heterogeneous neurosensory disorder
(Friedman and Grifﬁth 2003; Morton 2004; Smith
2004). We ascertained ∼600 families segregating non-
syndromic deafness. Here, we report 12 of these families,
7 of which are segregating mutant alleles of TRIOBP
on chromosome 22q13. The mouse ortholog Triobp
(also referred to as “Tara”) encodes a protein that ap-
pears to be involved in cytoskeletal organization (Seipel
et al. 2001).
After written informed consent was obtained, con-
sanguineous families segregating deafness as an auto-
somal recessive trait were recruited to our protocols.
Approval for this study was obtained from institutional
review boards in Pakistan, India, and the United States
(at the National Institutes of Health under protocol
OH93-N-016). Affected members of 11 of the 12 fam-
ilies reported herein (ﬁg. 1) had prelingual, severe-to-
profound hearing loss (audiograms shown in ﬁg. 2) with-
out any obvious associated symptoms or signs, such as
dysmorphology, night blindness, vestibular abnormali-
ties, goiter, and renal or cardiac defects, that might rep-
resent a syndromic form of deafness (Petit et al. 2001).
Physical examinations, including vestibular-function
testing, funduscopy, and/or electroretinogram, were con-
ducted on at least two affected individuals from each of
these families. Hearing was evaluated using pure-tone
audiometry. In family PKDF324, retinitis pigmentosa
segregated independently of deafness (data not shown).
By use of the Weber 9 marker panel and genomic
DNA from affected and unaffected members of family
PKSR28A, a genomewide linkage analysis was under-
taken after exclusion of linkage of deafness to genetic
markers at the known nonsyndromic recessive deafness
(DFNB) loci (Hereditary Hearing Loss Homepage). Evi-
dence of linkage of deafness segregating in PKSR28A
was detected with marker D22S272 on chromosome
22q13, with a two-point LOD score of 3.1. Haplo-
type analysis revealed an ∼10-cM region of homozy-
gosity delimited by markers D22S692 (41.42 cM) and
D22S274 (51.54 cM). Three STR markers (D22S692,
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Figure 1 Pedigrees of 12 consanguineous families from Pakistan and India. Blackened symbols represent individuals with clinically
documented congenital deafness. Genotype and haplotype data for families PKDF262 and DKB-01 are shown. For the chromosome 22q13
locus, the haplotype of affected individual IV:2 of family PKDF262 has a proximal breakpoint at D22S1180. Affected individual IV:1 of family
DKB-01 has a distal breakpoint at D22S1181, which reﬁnes the smallest linkage interval to 702 kb. However, when TRIOBP mutation–
containing families are removed, the minimal deafness-linkage interval is ∼10 cM, deﬁned by two of the remaining families, PKSR19A and
PKSR28A, with simulated LOD scores of 3.4 and 3.1, respectively (table 1).
D22S1045, and D22S272) at 22q13 were then used to
screen ∼600 families segregating recessive deafness. The
deafness phenotype segregating in ﬁve additional fami-
lies from Pakistan and six from India was consistentwith
linkage to genetic markers in this interval (ﬁg. 1 and
table 1). The largest family (PKDF262) (table 1) had a
two-point LOD score of 7.2 for D22S272.
Haplotype analysis of affected individuals in all the
families was used to reﬁne the genetic interval of this
DFNB locus. Family PKDF262 has 10 affected individ-
uals (9 ascertained) in three sibships. Individual IV:2 has
a proximal breakpoint for STR marker D22S1180 (ﬁg.
1) at 36164004 bp of the chromosome 22 sequence
(UCSC Genome Browser May 2004 assembly). Affected
individual IV:1 from family DKB-01 has a distal break-
point for the STR D22S1181 (ﬁg. 1) at 36866004 bp.
Family DKB-01 has only three affected siblings and does
not support a statistically signiﬁcant LOD score (table
1). Nevertheless, we proceeded with the positional clon-
ing of this DFNB gene under the assumption that this
small family, which shares a haplotype with a larger
family (DKH-14), was segregating a mutation in the
same gene responsible for deafness in the other 11 fam-
ilies. Thus, families PKDF262 and DKB-01 led to a ten-
tative reﬁnement of the smallest interval to ∼702 kb on
the chromosome 22 physical map, which is gene rich.
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Figure 2 Audiograms of one congenitally deaf individual from
each family. The carriers of a mutant allele have normal hearing.
Table 1
Family Data, Mutation of TRIOBP (and Effect on Triobp), and Allele Frequencies
Family Ethnicity
LOD at
vp 0
Pathogenic
Mutation/Polymorphism Protein Effect
Allele Frequency in
Control Population
DKB-01 Indian 1.8 889CrT Q297X 0/662
PKDF309 Pakistani 3.2 2362CrT R788X 0/608
PKDF262 Pakistani 10.2 3202CrT R1068X 0/616
HTN15 Indian 1.8 3202_3203delCG D1069fsX1082 0/616
IDM-05 Indian 1.8 3225_3226insC R1078fsX1083 0/616
DKH-14 Indian 2.9 3225_3226insC R1078fsX1083 0/616
CH-32/63 Indian 2.2 3349CrT R1117X 0/616
PKDF324 Pakistani 6.3 None (1193_1195delAAC) delQ398 33/180
PKSR19A Pakistani 3.4 None … …
PKSR28A Pakistani 3.1 None … …
IDM-17 Indian 1.8 None … …
PKDF228 Pakistani 1.8 None … …
NOTE.—Nucleotide changes are numbered according to the ﬁrst coding ATG in exon 2 of TRIOBP-6. LOD
scores were calculated using parameters described elsewhere (Ahmed et al. 2001)—in brief, the disease was
coded as fully penetrant, and the disease-allele frequency was set at 0.001. Meiotic recombination fractions
were assumed to be equal for males and females.
The linkage interval (ﬁgs. 1 and 3) for deafness segre-
gating in all these families overlaps the DFNB28 locus
reported elsewhere (Walsh et al. 2000).
There are 29 annotated genes in this 702-kb interval.
For all these genes, we sequenced the splice junctions
and all coding exons, using DNA from two affected
members each from at least six families (ﬁg. 3). Several
nucleotide variants were found for many of these genes
but were excluded as pathogenic mutations on the basis
of 11% frequency in the normal population, as reported
in SNP databases, or presence in at least 96 unaffected
control individuals from India and Pakistan (informa-
tion available on request). We also sequenced some of
the conserved predicted regulatory elements and all of
the exons of SOX10, since mutations of this gene are
known to be associated with a syndromic deafness,
Waardenburg syndrome type IV (WSIV [MIM 277580])
(Pingault et al. 1998). There is precedence for allelic
mutations associated with syndromic and nonsyndromic
forms of hereditary deafness (Bork et al. 2001; Petit et
al. 2001; Ahmed et al. 2002, 2003). However, we did
not ﬁnd a pathogenic mutation of SOX10.
One of the genes in the chromosome 22q13 inter-
val is TRIOBP (ﬁg. 3). The RefSeq mRNA entry for
TRIOBP isoform 1 (TRIOBP-1 [GenBank accession
number NM_007032]) has an ORF with a deduced
amino acid sequence containing 593 residues (Seipel et
al. 2001). However, two other mRNAs for TRIOBP
(GenBank accession numbers AB051449 and AK096634)
have ﬁve and seven additional exons, respectively, that
are located upstream of the reported exons and are part
of TRIOBP. On the basis of the presence of these ad-
ditional exons and our evaluation of 5′ and 3′ products
of rapid ampliﬁcation of cDNA ends (RACE) of the
mouse ortholog of TRIOBP, a more complete structure
of TRIOBP was assembled (ﬁg. 4A). Using cDNA tem-
plate synthesized from human inner-ear mRNA, we
identiﬁed additional exons of TRIOBP. There are also
predicted exons of TRIOBP based on the annotation in
the UCSC database.
We describe here three additional isoforms of human
TRIOBP (TRIOBP-3, TRIOBP-4, and TRIOBP-6
[GenBank accession numbers DQ228003, DQ228004,
and DQ228005, respectively]) (ﬁg. 4A). TRIOBP-6 is
the longest isoform and has 23 exons (ﬁg. 4A), of which
21 are coding. This protein has 2,365 aa residues (261
kDa). TRIOBP-3 and TRIOBP-4 are shorter tran-
scripts, encoding 2,193 and 1,144 aa residues, respec-
tively. Depending on the isoform, TRIOBP has ﬁve cop-
ies each of two repeated motifs encoded by exon 6, a
predicted pleckstrin homology (PH) domain, and four
coiled-coil regions (SMART [Schultz et al. 1998]) (ﬁg.
4B).
We sequenced all the exons of TRIOBP (ﬁg. 4A) in
genomic DNA of affected persons from each of the 12
families (ﬁg. 1). All exons were ampliﬁed by PCR from
genomic DNA in a 20-ml reaction volume, with primers
ﬂanking all the exon-intron boundaries (table 2) as de-
scribed elsewhere (Ahmed et al. 2001). We identiﬁed six
mutations (ﬁg. 4C and table 1), including four nonsense
mutations (Q297X, R788X, R1068X, and R1117X)
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Figure 3 Genetic map of the 22q13 locus deﬁned by proximal and distal meiotic breakpoints in families PKDF262 andDKB-01, respectively.
The Marshﬁeld map distance (Mfd) of polymorphic markers is shown (left) (see Center for Medical Genetics, Marshﬁeld Medical Research
Foundation Web site). The proximal breakpoint, D22S1180, and the distal breakpoint, D22S1181, are marked with an X on the chromosome.
Linked markers are shown as blackened circles on the chromosome. In two affected individuals from at least six of the families, we evaluated
the other 28 annotated genes in this interval for mutations but found none. TRIOBP is shown in bold italics.
and two frameshift mutations (D1069fsX1082 and
R1078fsX1083) (table 1). All these mutations were lo-
cated in exon 6 of TRIOBP, and all six alleles result in
truncations of the protein. Exon 6 is 3.319 kb and en-
codes 1,106 aa. None of these truncating mutations of
TRIOBP was detected in ∼300 DNA samples (table 1)
from unaffected Pakistani, Indian, and North American
control individuals.
No mutations of TRIOBP were identiﬁed in af-
fected individuals from families PKDF324, PKSR19A,
PKSR28A, IDM-17, and PKDF228. Three of these ﬁve
families have signiﬁcant LOD scores (table 1) indicating
linkage of deafness to chromosome 22q13 markers,
which suggests the presence of additional unknown
exons of TRIOBP, undetected mutations, or locus
heterogeneity.
From the mouse inner-ear cDNA library, we found
previously reported short isoforms (Triobp-1 and Triobp-
2) and three additional isoforms (Triobp-3, Triobp-4,
and Triobp-5 [GenBank accession numbers DQ228000,
DQ228002, and DQ228001, respectively]) (ﬁg. 5). The
longest isoform (Triobp-3) has 25 exons, of which 21
are coding and would produce a protein of 2,014 aa
(224 kDa) that is 65% identical to human TRIOBP-3
(ﬁg. 5A and 5B). Four consecutive exons of mouse
Triobp-3 (exons 5–8) correspond to the sequence en-
coded by exon 6 (3,319 bp) of human TRIOBP. In ad-
dition to characterizing the isoforms of Triobp, we also
determined the expression pattern of Triobp isoforms in
various tissues. Triobp-1 is widely expressed (ﬁg. 5C),
as reported elsewhere (Seipel et al. 2001), whereas other
isoforms have a more limited pattern of expression (ﬁg.
Figure 4 Structure and mutations of TRIOBP associated with deafness. A, Schematic representation of the genomic structure of isoforms
of human TRIOBP and the locations of the mutations in exon 6 associated with deafness. Arrows represent the location of the primers used
for RT-PCR. Red dots indicate the site of the mutations in exon 6 of TRIOBP. B, Protein structure of TRIOBP-6. There are ﬁve copies each
of two different repeated motifs (dark blue and light blue rectangles) that have the amino acid sequences TPCA/I/TQR/WDNPRASSPNRT/ST/
AQRDN/SPR and VCIGHRDAPRAS/TS/FPP. C, Mutations of TRIOBP segregating in six families. Electropherograms of amplimers from
genomic DNA templates illustrate homozygosity for mutations found in all affected family members and homozygosity for the wild-type allele
in an unaffected individual. All obligate carriers are heterozygous (not shown). All of the mutations described here are numbered beginning
with 1 at the A base of the translation start codon (ATG) in exon 2 of TRIOBP-6. The stop codons due to nonsense mutations are underlined.
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Figure 5 Genomic structure of Triobp mouse isoforms and their expression in various tissues. A, Triobp splice variants. There are at least
ﬁve different splice variants present in the mouse inner ear, including the previously reported short isoforms (Triobp-1 and Triobp-2). Locations
of the primers used for RT-PCR expression proﬁle are shown as arrowheads. B, Predicted protein products of different Triobp splice variants.
Triobp-4 does not encode the PH domain and the coiled-coil regions. Triobp-1 encodes only the PH domain and the four coiled-coil domains.
C, Expression proﬁles of Triobp-1, Triobp-3/5, and Triobp-4. PCR primers (table 2), shown as arrowheads in panel A, were designed to amplify
each isoform from cDNA prepared from different mouse tissues. Left proﬁle, Triobp-1 is widely expressed, whereas other isoforms have a more
limited pattern of expression. Triobp-3 (arrow) is present in the brain, liver (faint band), kidney (faint band), retina (P15), and inner ear (P1–
P5). Middle proﬁle,Triobp-5 (arrowhead) is found in mouse embryo cDNA (E11.5), brain, kidney (faint band), retina, pancreas (faint band),
and inner ear. Right proﬁle, Triobp-4 seems to be expressed in kidney (faint band), retina, testis (faint band), and inner ear. These transcripts
do not provide an exhaustive list of the isoforms of Triobp. A smaller, uncharacterized cDNA is present in many tissues (middle proﬁle). There
are 33 inner-ear RIKEN ESTs for Triobp (168–488 bp; not shown). PCR ampliﬁcation of Actn1 cDNA encoding a-actinin was used as a control
for the quality and quantity of RT-PCR templates.
5C). Triobp-3 is present in the brain, liver, kidney, retina,
and inner ear, whereas Triobp-5 is found in the whole
embryo, brain, kidney, retina, pancreas, and inner ear
(ﬁg. 5C). Triobp-4 seems to be expressed in the kidney,
retina, testis, and inner ear (ﬁg. 5C).
Relatively little is know about the function of Triobp.
In a yeast two-hybrid screen, a Triobp isoform equiva-
lent to Triobp-1 (ﬁg. 5B) was identiﬁed as a protein that
interacts with Trio, which is a member of a large family
of Dbl homology guanine nucleotide exchange factors
(DH-GEFs). DH-GEFs are involved in activating Rho
guanosine triphosphatases (Rossman et al. 2005), which
mediate a variety of cellular functions, including actin
remodeling (Rossman et al. 2005). Triobp is also re-
ported to have ﬁlamentous actin (F-actin) bundling ac-
tivity on the basis of an in vitro binding assay in HeLa
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Table 2
Primers Used to Sequence 24 Exons of TRIOBP and
for Cloning Full-Length Isoforms and RT-PCR
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
cells (Seipel et al. 2001). Moreover, Triobp-1 stabilizes
F-actin structures, as indicated by the relative resistance
of Triobp-1–expressing cells to latrunculin B, an F-actin
destabilizer (Seipel et al. 2001). Perhaps in the inner ear,
the function of Triobp-1 is important for formation or
stabilization of the cytoskeletal structure of stereocilia
and/or the cuticular plate, both actin-rich structures in
sensory hair cells (Frolenkov et al. 2004). However, all
six mutations causing deafness in humans are located in
exon 6 of TRIOBP (equivalent to exons 5–8 of mouse
Triobp), which encodes an amino acid sequence that is
not present in Triobp-1 (ﬁg. 5). Given the complex al-
ternative splicing of this gene, it appears that a variety
of isoform-speciﬁc mutations of Triobp and antisera to
Triobp will be essential to understanding the normal
function of this gene in the auditory system.
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